|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.965 USD | -4.46% |
|
+2.06% | -17.29% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
July 5 (Reuters) - European Medicines Agency:
* EMA: EMA'S CHMP APPROVED A NEW MANUFACTURING SITE FOR THE ACTIVE SUBSTANCE OF COVID-19 VACCINE NUVAXOVID: 05/07/2022 Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| -17.29% | 581M | |
| +0.63% | 43.84B | |
| +5.82% | 41.68B | |
| +45.26% | 41.25B | |
| -11.96% | 27.04B | |
| +5.62% | 25.53B | |
| -24.92% | 18.18B | |
| -3.46% | 12.29B | |
| +25.76% | 12.29B | |
| +6.69% | 11.15B |
NOVAVAX, INC. 
